We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Camilleri

Michael Camilleri MD

Consultant in the Division of Gastroenterology and Hepatology in the Department of Internal Medicine at Mayo Clinic in Rochester, Minnesota

Michael Camilleri, M.D., is a consultant in the Division of Gastroenterology and Hepatology in the Department of Internal Medicine at Mayo Clinic in Rochester, Minnesota. He was recognized with the Atherton and Winifred W. Bean Professorship in 2001 and as a Mayo Distinguished Investigator in 2008. He holds the ranks of Professor of Medicine, Pharmacology, and Physiology at Mayo Clinic College of Medicine. He joined the staff of Mayo Clinic in 1990. He currently serves as Executive Dean for the Department of Development at Mayo Clinic. He is the immediate past-president of the American Gastroenterological Association Institute and currently serves as chair of the American Gastroenterological Association. He has served as Chair of the Food and Drug Administration’s Gastrointestinal Drugs Advisory Committee and as a member of study sections of NIDDK at National Institutes of Health.

Dr. Camilleri received his M.D. degree from University of Malta Medical School and completed residency at St. Luke’s University Hospital in Malta. He pursued fellowships in research and internal medicine and gastroenterology at Hammersmith Hospital at the University of London, England. He completed fellowships at Mayo Graduate School in both research and clinical studies in gastroenterology. His research interests include clinical enteric neurosciences, gut neurohormonal control, obesity, irritable bowel syndrome, and pharmacology and pharmacogenomics. Formerly, he was editor of Clinical Gastroenterology and Hepatology and of Neurogastroenterology and Motility, and was associate editor of Gastroenterology. He is currently an associate editor of American Journal of Physiology. He has published extensively in high-impact scientific journals such as New England Journal of Medicine, Gastroenterology, American Journal of Physiology, Neurogastroenterology and Motility, Gut, and American Journal of Gastroenterology.